A. Renaud
-
- Lung Cancer Treatments and Mutations 4
- Radiation top 5%
- Otorhinolaryngology top 5%
- Oncology top 5%
- Peptidase Inhibition and Analysis 4
- Lung Cancer Research Studies 2
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Protease and Inhibitor Mechanisms 4
-
- Amino Acid Enzymes and Metabolism 1
-
- Chemical Synthesis and Analysis 1
-
- Pain Management and Opioid Use 1
A. Renaud
13 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Pulmonary and Respiratory Medicine 883
- Radiation 214
- Otorhinolaryngology 96
- Oncology 534
- Hepatology 77
Countries citing papers authored by A. Renaud
This map shows the geographic impact of A. Renaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Renaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Renaud more than expected).
Fields of papers citing papers by A. Renaud
This network shows the impact of papers produced by A. Renaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Renaud. The network helps show where A. Renaud may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Renaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2015 | 0 | |
| 3 | 2005 | 44 | |
| 4 | Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound. | 2001 | 54 |
| 5 | 2000 | 22 | |
| 6 | 1999 | 56 | |
| 7 | 1994 | 22 | |
| 8 | 1993 | 2 | |
| 9 | 1993 | 9 | |
| 10 | Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancerbreakdown → | 1992 | 998 |
| 11 | 1983 | 32 | |
| 12 | 1980 | 15 | |
| 13 | 1979 | 19 | |
| 14 | 1979 | 10 |
About A. Renaud
A. Renaud is a scholar working on Hepatology, Cancer Research and Oncology, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Research Studies (2 papers), Amino Acid Enzymes and Metabolism (1 paper), Chemical Synthesis and Analysis (1 paper) and Pain Management and Opioid Use (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (883 citations), Radiation (214 citations) and Otorhinolaryngology (96 citations). A. Renaud has collaborated with scholars based in France, Netherlands and Canada. Frequent co-authors include Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink, B. Maat, C. Schaake-Koning, Jan Festen, Patrick Rodrigus, Otilia Dalesio, Anne Kirkpatrick and Mia G.J. Koolen. Their work appears in journals such as Journal of Biological Chemistry, Lung Cancer, Clinical Nutrition, Gut Pathogens and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.